Pediatric meningococcocal meningitis in the acute phase: how much does it cost?

Elena Bozzola, Stefano Guolo, Enea Bonci, Chiara Rossetti, Mauro Bozzola, Massimiliano Raponi, Alberto Villani

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Meningococcal meningitis (MM) is known to be responsible of high cost for the Public Health Administration. Aim of the work is to calculate the costs for the hospitalization of pediatric patients affected by MM.

METHODS: We calculate the costs for the hospitalization of pediatric patients affected by MM in the acute phase (HAP) over a nine year period. We performed a MEDLINE search to verify the cost of MM HAP reported in other studies.

RESULTS: At Bambino Gesù Children Hospital, the median cost of HAP was of 12,604 euro (range from 9203 to 35,050 euro). Comparing our data with the previous studies, we find out similar results of approximately 16,750 euro (range 12,000-20,000 euro).

DISCUSSION: Despite the relative rarety of the disease, MM is associated to direct high cost of HAP.

CONCLUSIONS: Hospital costs are an important end-point in health economic evaluation of the disease and may be useful to policy makers and health economists to understand the potential benefit of improving meningococcal vaccination programmes.

Original languageEnglish
Pages (from-to)25
JournalItalian Journal of Pediatrics
Volume45
Issue number1
DOIs
Publication statusPublished - Feb 13 2019

Fingerprint

Meningococcal Meningitis
Meningitis
Pediatrics
Costs and Cost Analysis
Hospital Costs
Hospitalization
Public Health Administration
Health
Administrative Personnel
MEDLINE
Cost-Benefit Analysis
Vaccination

Cite this

Pediatric meningococcocal meningitis in the acute phase : how much does it cost? / Bozzola, Elena; Guolo, Stefano; Bonci, Enea; Rossetti, Chiara; Bozzola, Mauro; Raponi, Massimiliano; Villani, Alberto.

In: Italian Journal of Pediatrics, Vol. 45, No. 1, 13.02.2019, p. 25.

Research output: Contribution to journalArticle

@article{5e9f8e2b99194b148a0f6a9df38a4647,
title = "Pediatric meningococcocal meningitis in the acute phase: how much does it cost?",
abstract = "BACKGROUND: Meningococcal meningitis (MM) is known to be responsible of high cost for the Public Health Administration. Aim of the work is to calculate the costs for the hospitalization of pediatric patients affected by MM.METHODS: We calculate the costs for the hospitalization of pediatric patients affected by MM in the acute phase (HAP) over a nine year period. We performed a MEDLINE search to verify the cost of MM HAP reported in other studies.RESULTS: At Bambino Ges{\`u} Children Hospital, the median cost of HAP was of 12,604 euro (range from 9203 to 35,050 euro). Comparing our data with the previous studies, we find out similar results of approximately 16,750 euro (range 12,000-20,000 euro).DISCUSSION: Despite the relative rarety of the disease, MM is associated to direct high cost of HAP.CONCLUSIONS: Hospital costs are an important end-point in health economic evaluation of the disease and may be useful to policy makers and health economists to understand the potential benefit of improving meningococcal vaccination programmes.",
author = "Elena Bozzola and Stefano Guolo and Enea Bonci and Chiara Rossetti and Mauro Bozzola and Massimiliano Raponi and Alberto Villani",
year = "2019",
month = "2",
day = "13",
doi = "10.1186/s13052-019-0616-z",
language = "English",
volume = "45",
pages = "25",
journal = "Italian Journal of Pediatrics",
issn = "1720-8424",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Pediatric meningococcocal meningitis in the acute phase

T2 - how much does it cost?

AU - Bozzola, Elena

AU - Guolo, Stefano

AU - Bonci, Enea

AU - Rossetti, Chiara

AU - Bozzola, Mauro

AU - Raponi, Massimiliano

AU - Villani, Alberto

PY - 2019/2/13

Y1 - 2019/2/13

N2 - BACKGROUND: Meningococcal meningitis (MM) is known to be responsible of high cost for the Public Health Administration. Aim of the work is to calculate the costs for the hospitalization of pediatric patients affected by MM.METHODS: We calculate the costs for the hospitalization of pediatric patients affected by MM in the acute phase (HAP) over a nine year period. We performed a MEDLINE search to verify the cost of MM HAP reported in other studies.RESULTS: At Bambino Gesù Children Hospital, the median cost of HAP was of 12,604 euro (range from 9203 to 35,050 euro). Comparing our data with the previous studies, we find out similar results of approximately 16,750 euro (range 12,000-20,000 euro).DISCUSSION: Despite the relative rarety of the disease, MM is associated to direct high cost of HAP.CONCLUSIONS: Hospital costs are an important end-point in health economic evaluation of the disease and may be useful to policy makers and health economists to understand the potential benefit of improving meningococcal vaccination programmes.

AB - BACKGROUND: Meningococcal meningitis (MM) is known to be responsible of high cost for the Public Health Administration. Aim of the work is to calculate the costs for the hospitalization of pediatric patients affected by MM.METHODS: We calculate the costs for the hospitalization of pediatric patients affected by MM in the acute phase (HAP) over a nine year period. We performed a MEDLINE search to verify the cost of MM HAP reported in other studies.RESULTS: At Bambino Gesù Children Hospital, the median cost of HAP was of 12,604 euro (range from 9203 to 35,050 euro). Comparing our data with the previous studies, we find out similar results of approximately 16,750 euro (range 12,000-20,000 euro).DISCUSSION: Despite the relative rarety of the disease, MM is associated to direct high cost of HAP.CONCLUSIONS: Hospital costs are an important end-point in health economic evaluation of the disease and may be useful to policy makers and health economists to understand the potential benefit of improving meningococcal vaccination programmes.

U2 - 10.1186/s13052-019-0616-z

DO - 10.1186/s13052-019-0616-z

M3 - Article

C2 - 30760306

VL - 45

SP - 25

JO - Italian Journal of Pediatrics

JF - Italian Journal of Pediatrics

SN - 1720-8424

IS - 1

ER -